scholarly journals Long-Term Follow-Up after Transvenous Single Coil Embolization of Patent Ductus Arteriosus in Dogs

2010 ◽  
Vol 24 (6) ◽  
pp. 1400-1406 ◽  
Author(s):  
N. Hildebrandt ◽  
C. Schneider ◽  
T. Schweigl ◽  
M. Schneider
2012 ◽  
Vol 8 (2) ◽  
pp. 159-166 ◽  
Author(s):  
Fadli Demir ◽  
Ahmet Celebi ◽  
Turkay Saritas ◽  
Abdullah Erdem ◽  
Halil Demir ◽  
...  

2018 ◽  
Vol 71 (11) ◽  
pp. A577
Author(s):  
Erin Nealon ◽  
Corey Stiver ◽  
Clifford Cua ◽  
Claire Mitchell ◽  
Brian Boe ◽  
...  

2003 ◽  
Vol 44 (11) ◽  
pp. 480-490 ◽  
Author(s):  
N. Van Israel ◽  
J. Dukes-McEwan ◽  
A. T. French

2001 ◽  
Vol 88 (5) ◽  
pp. 586-588 ◽  
Author(s):  
Roberto Formigari ◽  
Alessandra Toscano ◽  
Ignacio Herraiz ◽  
Jacek Bialkowski ◽  
Andrea Donti ◽  
...  

Author(s):  
Dor Markush ◽  
Jennifer C. Tsing ◽  
Surbhi Gupta ◽  
Nicole C. Berndsen ◽  
Geena Radville ◽  
...  

AbstractTranscatheter patent ductus arteriosus closure (TCPC) is an emerging treatment for low birth weight extremely premature neonates (EPNs). Left pulmonary artery (LPA) and descending aorta (DAO) obstruction are described device-related complications, however, data on mid- and long-term vascular outcomes are lacking. A retrospective analysis of EPNs who underwent successful TCPC at our institution from 03/2013 to 12/2018 was performed. Two-dimensional echocardiography and spectral Doppler velocities from various time points before and after TCPC were used to identify LPA and DAO flow disturbances. A total of 44 EPNs underwent successful TCPC at a median (range) procedural weight of 1150 g (755–2500 g). Thirty-two (73%) patients were closed with the AVP II and 12 (27%) with the Amplatzer Piccolo device. LPA and DAO velocities on average remained within normal limits and improved spontaneously in long-term follow up (26.1 months, range 1–75 months). One patient, who had concerning LPA flow characteristics immediately after device implant (peak velocity 2.6 m/s) developed progressive LPA stenosis requiring stent placement 3 months post-procedure. In the remaining infants, including 7 (16%) who developed LPA and 3 (7%) who developed DAO flow disturbances (range 2–2.4 m/s), all had progressive normalization of flow velocities over time. TCPC can be performed safely in EPNs with a low incidence of LPA and DAO obstruction. In the absence of significant progressive vascular obstruction in the early post-procedure period, mild increases in LPA and DAO flow velocities tend to improve spontaneously and normalize in long-term follow-up.


2020 ◽  
Vol 68 (1) ◽  
Author(s):  
Reem M. Soliman ◽  
Fatma Alzahraah Mostafa ◽  
Antoine Abdelmassih ◽  
Elham Sultan ◽  
Dalia Mosallam

Abstract Background Patent ductus arteriosus poses diagnostic and therapeutic dilemma for clinicians, diagnosis of persistent PDA, and determination of its clinical and hemodynamic significance are challenging. The aim of this study is to determine the prevalence of PDA in preterm infants admitted to our NICU, to report cardiac and respiratory complications of PDA, and to study the management strategies and their subsequent outcomes. Result Echocardiography was done for 152 preterm babies admitted to neonatal intensive care unit (NICU) on day 3 of life. Eighty-seven (57.2%) preterms had PDA; 54 (62.1%) non-hemodynamically significant PDA (non-hsPDA), and 33 (37.9%) hemodynamically significant PDA. Hemodynamically significant PDA received medical treatment (paracetamol 15 mg/kg/6 h IV for 3 days). Follow-up echocadiography was done on day 7 of life. Four babies died before echo was done on day 7. Twenty babies (68.9%) achieved closure after 1st paracetamol course. Nine babies received 2nd course paracetamol. Follow-up echo done on day 11 of life showed 4 (13.7%) babies achieved successful medical closure after 2nd paracetamol course; 5 babies failed closure and were assigned for surgical ligation. The group of non-hsPDA showed spontaneous closure after conservative treatment. Pulmonary hemorrhage was significantly higher in hsPDA group. Mortality was higher in hsPDA group than non-hsPDA group. Conclusion Echocardiographic evaluation should be done for all preterms suspected clinically of having PDA. We should not expose vulnerable population of preterm infants to medication with known side effects unnecessarily; we should limit medical closure of PDA to hsPDA. Paracetamol offers several important therapeutic advantages options being well tolerated and having more favorable side effects profile.


Sign in / Sign up

Export Citation Format

Share Document